52428-09-8

Basic information

• Product Name: 4 7-DIMETHOXY-1-INDANONE 97
• Synonyms: 4 7-DIMETHOXY-1-INDANONE 97;4,7-DIMETHOXY-2,3-DIHYDRO-1H-INDEN-1-ONE;2,3-Dihydro-4,7-dimethoxy-1H-inden-1-one;4,7-DIMETHOXY-2,3-DIHYDROINDEN-1-ONE;4,7-dimethoxy-1H-inden-1-one
• CAS NO: 52428-09-8
• Molecular Formula: C₁₁H₁₂O₃
• Molecular Weight: 192.21
• Product Categories: C11 to C12;Carbonyl Compounds;Ketones
• Mol File: 52428-09-8.mol
• Article Data: 10

Chemical Properties

• Melting Point: 122-125 °C(lit.)
• Boiling Point: 352.6 ºC at 760 mmHg
• Flash Point: 158.3 ºC
• Appearance: /
• Density: 1.179
• Vapor Pressure: 3.79E-05mmHg at 25°C
• Refractive Index: 1.549
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4 7-DIMETHOXY-1-INDANONE 97(CAS DataBase Reference)
• NIST Chemistry Reference: 4 7-DIMETHOXY-1-INDANONE 97(52428-09-8)
• EPA Substance Registry System: 4 7-DIMETHOXY-1-INDANONE 97(52428-09-8)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 52428-09-8(Hazardous Substances Data)

Usage

Uses

4,7-Dimethoxy-1-indanone acts as a reagent for the synthesis and biological evaluation of indenopyrazine dicarbonitrile as inhibitors of deubiquitinating enzymes.

InChI:InChI=1/C11H12O3/c1-13-9-5-6-10(14-2)11-7(9)3-4-8(11)12/h5-6H,3-4H2,1-2H3

Upstream product

• 10538-49-5 3-(2,5-dimethoxyphenyl)propanoic acid 
• 71-43-2 benzene 
• 10538-51-9 2,5-dimethoxycinnamic acid 
• 93-02-7 2,5-dimethoxybenzaldehyde 
• 848610-51-5 5-(2,5-dimethoxybenzyl)-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 150-78-7 1,4-dimethoxybezene 
• 2680-03-7 N,N-Dimethylacrylamide 
• 100126-94-1 3-(2,5-dimethoxyphenyl)propionyl chloride 
• 38489-74-6 trans-2,5-dimethoxycinnamic acid 

Downstream Products

• 78572-95-9 4,7-dimethoxy-3-methylindene 
• 134663-15-3 1-(but-3-enyl)-4-hydroxy-7-methoxyindane 
• 134663-14-2 1-(but-3-enyl)-4,7-dimethoxyindane 
• 134663-27-7 (1-But-3-enyl-7-methoxy-indan-4-yloxy)-trimethyl-silane 
• 1649451-24-0 2,2,9,9,16,16,23,23-octabutyltetraindanotetraoxa[8]circulene 
• 1649451-33-1 2,2-diethyl-4,7-dimethoxyindane 
• 1649451-34-2 2,2-dibutyl-4,7-dimethoxyindane 
• 1649451-35-3 2,2-dihexyl-4,7-dimethoxyindane 
• 1649451-36-4 4,7-dimethoxy-2,2-dioctylindane 
• 1649451-29-5 2,2-dibutyl-2,3-dihydro-1H-indene-4,7-dione 
• 1649451-30-8 2,2-dihexyl-2,3-dihydro-1H-indene-4,7-dione 
• 1649451-31-9 2,3-dihydro-2,2-dioctyl-1H-indene-4,7-dione 
• 290352-25-9 4,7-dimethoxy-2,2-dimethylindane-1-one 
• 1649451-37-5 2,2-diethyl-4,7-dimethoxyindane-1-one 

Relevant articles and documents

Stereoselective Synthesis of [4.3.1]Propellane Fragment of Phainanoids A–F

-

SPIRO COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS

Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.

SPIRO RING COMPOUND AS HEPATITIS C VIRUS (HCV) INHIBITOR AND USES THEREOF FIELD OF THE INVENTION

A compound of formula (I) or a stereoisomer, a geometric isomer. a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof is provided, which can be used for treating HCV infection or a HCV disorder. Also a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof are provided, which can also be used for treating HCV infection or a HCV disorder.